1Lefranc F, Rynkowski M, DeWitte O, et al. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg, 2009 , 34 : 3 -35.
2Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol, 2004, 5 ( 7 ) : 738- 743.
3Nelson R. Brain-cancer stem cells may drive tumour formation. Lancet Neurol, 2005, 4(1) :17.
4Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44 + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene, 2006, 25(12) : 1696-1708.
5Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamouscell carcinoma. Natl. Acad. Sci, 2007,104(3) : 973-978.
6O ' Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445(7123) : 106-110.
7Sanai N, Alvarez-Buylla A, Berger MS, et al. Neural stem cells and the origin of gliomas. N Engl J Med, 2005 , 353 (8) : 811-822.
8Taylor M. D, Poppleton H, Fuller C, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell, 2005, 8(4) : 323-335.
9Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 2004, 64 ( 19 ) : 7011- 7021.
10Liu Q, Nguyen DH, Dong Q, et al. Molecular properties of CD133^+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. Neurooncol,2009, 94 (1) :1 -19.
2Stupp R, Mason WP, van den Bent MJ, et 81. Radiotherapy plus eon2comitant and adjuvant temozolomide for glioblastoma [ J ]. N Engl J Med, 2005,352(10) :9872-9996.
3Ehtesham M, Mapara KY, Stevenson CB, et al. CXCR4 mediatesthe proliferation of glioblastoma progenitor cells [ J ]. Cancer Lett, 2009,274(2) :305-312.
4Johannessen TC, Bjerkvig R, Tysnes BB. DNA repair and cancer stem-like cells-potential partners in glioma drug resistance [ J ]. Cancer Treat Rev, 2008,34 (6) :558 -567.
5Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J]. Nature, 2006,444(7120) :756-760.
